DEF: Olaplex 2026 Proxy Statement: Key Governance & Compensation

Olaplex Holdings, Inc. announces its 2026 Annual Meeting of Stockholders to be held virtually on July 9, 2026, covering director elections, executive compensation, and auditor ratification.

Summary

• The 2026 Annual Meeting of Stockholders will be held virtually on July 9, 2026, at 11:00 a.m. ET.
• Stockholders will vote on the election of four Class II directors, an advisory vote on 2025 executive compensation, and the ratification of Deloitte & Touche LLP as the independent auditor for 2026.
• The company entered into a merger agreement with Henkel US Operations Corporation on March 26, 2026.
• In connection with the merger, the company amended its Tax Receivable Agreement, which will terminate upon the effective time of the merger.
• The company reported a net loss of $9.25 million for fiscal year 2025, with an adjusted EBITDA of $93.87 million.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a transitional filing; while the company is navigating litigation and financial losses, the announcement of a merger with Henkel provides a clear, albeit definitive, path forward for shareholders.

Positives

• Achieved 103% of target performance goals for the 2025 annual cash bonus program.
• Maintains robust corporate governance policies, including clawback policies and stock ownership guidelines for executives and directors.
• Successfully completed the acquisition of Purvala Bioscience, Inc. in August 2025 to enhance biotechnology capabilities.
• Strong stockholder support for previous 'say-on-pay' votes, with 91% and 99% support in 2023 and 2024, respectively.

Negatives

• Reported a net loss of $9.25 million for the fiscal year ended December 31, 2025.
• The company is a 'controlled company' under Nasdaq rules, meaning it is exempt from certain independence requirements for its Board and committees.
• Significant litigation-related expenses of $9.15 million were incurred in 2025 related to the Lilien securities class action.

Risks

• Ongoing litigation related to the Lilien securities class action.
• Risks associated with information technology systems, including cybersecurity, data privacy, and the use of artificial intelligence.
• Potential integration risks following the acquisition of Purvala Bioscience, Inc.
• Dependence on the 'controlled company' status which limits independent oversight.

Future Outlook

The company is moving toward a merger with Henkel US Operations Corporation, which is expected to result in the termination of the existing Tax Receivable Agreement and the cancellation of outstanding equity awards for cash payments.

Management Comments

• The Board believes that having an Executive Chair and Lead Director provides effective management of the Company.
• The Board believes that the current board structure promotes continuity and stability of strategy.

Industry Context

StockSavvy.ai notes that Olaplex is navigating a challenging period in the beauty sector, characterized by increased competition and legal headwinds, while simultaneously pursuing a strategic exit via merger with a major industry player, Henkel.

Comparison to Industry Standards

• The company's peer group for compensation benchmarking includes personal products companies such as e.l.f. Beauty, Inc., Coty Inc., and Edgewell Personal Care Company.
• The company's executive compensation structure, including the use of performance-based bonuses and equity awards, aligns with standard practices for publicly traded consumer goods companies.

Corporate Governance

Legal Proceedings

• The company is involved in the Lilien securities class action, which resulted in $9.15 million in litigation-related expenses in 2025.

Related Party Transactions

• The company maintains a Tax Receivable Agreement with pre-IPO stockholders, which was amended in March 2026.
• The company acquired Purvala Bioscience, Inc., where the chief science and research officer was a stockholder and board member.
• The company engaged Heidrick & Struggles for recruiting services, a firm in which funds affiliated with Advent International (a majority shareholder) acquired a stake.

Stakeholder Impact

• Shareholders are expected to be impacted by the pending merger with Henkel.
• Employees and management are subject to the terms of the merger agreement regarding the treatment of equity awards.

Next Steps

• Hold the 2026 Annual Meeting of Stockholders on July 9, 2026.
• Complete the merger with Henkel US Operations Corporation.
• Terminate the Tax Receivable Agreement upon the effective time of the merger.

Key Dates

Recommendation

Given the pending merger with Henkel, the stock is likely to trade in line with the merger consideration, making a 'hold' recommendation appropriate for investors awaiting the completion of the transaction.

Keywords

Olaplex, Proxy Statement, Corporate Governance, Executive Compensation, Merger, Henkel, Annual Meeting